Results 271 to 280 of about 59,185 (303)

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

Nature Reviews Immunology, 2021
John S Tregoning, Ziyin Wang, Benjamin F Pierce   +2 more
exaly  

Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program.

Vaccine, 2020
Jialing Lin, J. Wood, C. Bernardo, N. Stocks, Bette Liu   +4 more
semanticscholar   +1 more source

Herpes Zoster Vaccines

2017
Michael N. Oxman, Ruth Harbecke
openaire   +1 more source

A systematic literature review of the recombinant subunit herpes zoster vaccine use in immunocompromised 18-49 year old patients.

Vaccine, 2020
Etienne B. Racine, V. Gilca, R. Amini, M. Tunis, S. Ismail, C. Sauvageau   +5 more
semanticscholar   +1 more source

COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

Nature Medicine, 2021
Julio S Solís Arce, Shana S Warren, Niccolò F Meriggi   +2 more
exaly  

Looking beyond COVID-19 vaccine phase 3 trials

Nature Medicine, 2021
Jerome H Kim, Florian Marks, John D Clemens   +2 more
exaly  

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Nature Medicine, 2021
Xuping Xie, Jianying Liu, Jing Zou
exaly  

Herpes Zoster Vaccines

2019
Anthony L. Cunningham, Myron J. Levin, Thomas C. Heineman   +2 more
openaire   +1 more source

A global survey of potential acceptance of a COVID-19 vaccine

Nature Medicine, 2020
Jeffrey V Lazarus, Adam Palayew, Heidi J Larson   +2 more
exaly  

Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan.

Vaccine, 2019
S. Hoshi, X. Seposo, Aiko Shono, I. Okubo, M. Kondo   +4 more
semanticscholar   +1 more source